Evidence-based·Updated November 16, 2026·How we grade evidence

Valsartan

MedicationAngiotensin receptor blocker (prescription)

Valsartan lowers blood pressure about as much as other ARBs and ACE inhibitors, cut hospital stays for heart failure in a large trial without changing survival, and was as effective as captopril after a heart attack with a weakened heart. Adding it to an ACE inhibitor brought more side effects without better survival. Its most important risks are harm to a developing baby (boxed warning), high blood potassium and reduced kidney function in vulnerable people. For supplements and foods, potassium supplements and potassium salt substitutes are the main concern; celery and spirulina may add a little to its blood pressure lowering.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with high blood pressure, heart failure, or a weakened heart after a heart attack, and children 1 year and older with high blood pressure, treated and monitored by a prescriber

Common dosing range

Set by your prescriber. For adult high blood pressure, Diovan starts at 80 or 160 mg once daily (range 80 to 320 mg), while Prexxartan oral solution has its own twice-daily dosing; for heart failure, 40 mg twice daily, raised to 160 mg twice daily as tolerated; after a heart attack, 20 mg twice daily, raised toward 160 mg twice daily

When to expect effects

Blood pressure starts falling about 2 hours after a dose; the label says the effect is largely present within 2 weeks and maximal after about 4 weeks

Watch out for

Boxed warning: it can harm or kill a developing baby, so tell your prescriber at once if you become pregnant. It can raise blood potassium, especially with kidney disease, heart failure, potassium supplements, potassium salt substitutes or potassium-sparing diuretics, and can worsen kidney function in people whose kidneys depend on angiotensin II. Do not combine it with aliskiren if you have diabetes

What is it

Valsartan is a prescription angiotensin II receptor blocker (ARB) used to lower high blood pressure in adults and children 1 year and older, to reduce hospital stays for heart failure, and to lower the risk of dying from heart causes in people whose heart is weakened after a heart attack. It is sold as Diovan and generic valsartan tablets, and as Prexxartan oral solution, whose label covers high blood pressure in adults and in children 6 years and older (not younger children) and says it is not therapeutically equivalent to Diovan tablets; it is also one of the two ingredients in sacubitril/valsartan (Entresto) and in several combination blood pressure pills. It carries a boxed warning: drugs that act on the renin-angiotensin system can injure and kill a developing baby, so it is stopped as soon as pregnancy is found. Because it can raise blood potassium, potassium supplements and potassium salt substitutes are the key supplement concern.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

Your prescriber recommends an ARB for high blood pressure, heart failure, or a weakened heart after a heart attack, including if you had a cough on an ACE inhibitor
You can keep up with the blood tests for potassium and kidney function your prescriber orders
You are willing to check every supplement and salt substitute with your doctor or pharmacist, especially anything containing potassium

Probably skip if…

You are pregnant: the boxed warning says to stop it as soon as pregnancy is detected
You have diabetes and take aliskiren: the label contraindicates the combination
You have had angioedema (swelling of the face, lips or throat) on valsartan: the label says it should not be given again
You plan to keep using potassium supplements or potassium salt substitutes without your prescriber knowing and checking your blood potassium

Evidence at a glance

blood pressure

Good Evidence
Effect
About 8/5 mmHg lower than placebo at trough for the ARB class
Best fit
Adults with high blood pressure, including those who had a cough on an ACE inhibitor
Time
Largely present within 2 weeks, maximal after about 4 weeks

hospital stays for heart failure

Good Evidence
Effect
About 13 percent lower combined morbidity and mortality; heart failure hospital stays 13.8 versus 18.2 percent
Best fit
Adults with heart failure with reduced ejection fraction who cannot take an ACE inhibitor
Time
Assessed over about 2 years

survival in chronic heart failure

Good Evidence
Effect
No difference in deaths
Best fit
Not applicable
Time
Assessed over about 2 years

survival after a heart attack with heart failure or a weakened heart

Good Evidence
Effect
Same death rate as captopril (hazard ratio 1.00); no gain from combining them
Best fit
Adults after a heart attack with heart failure or a weakened heart, especially those who cannot take an ACE inhibitor
Time
Assessed over a median of about 2 years

Evidence for 4 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

blood pressure

Biomarker support
Good Evidence

A Cochrane review of 46 short randomized trials (3 to 12 weeks, 13,451 people with a starting blood pressure of 156/101 mmHg) found no meaningful difference between ARBs, including valsartan. Because of publication bias, the reviewers took the largest trials as the best estimate: about 8 mmHg lower systolic and 5 mmHg lower diastolic pressure at trough than placebo at the maximum recommended dose, similar to ACE inhibitors, with 60 to 70 percent of that effect at usual starting doses. The Diovan label reports placebo-corrected drops of about 6 to 9/3 to 5 mmHg at 80 to 160 mg and 9/6 mmHg at 320 mg. Blood pressure is a marker; the label notes there are no trials showing Diovan itself reduces heart events in high blood pressure.

Effect size
About 8/5 mmHg lower than placebo at trough for the ARB class
Time to effect
Largely present within 2 weeks, maximal after about 4 weeks
Best fit
Adults with high blood pressure, including those who had a cough on an ACE inhibitor
Less likely
People who need a large drop in blood pressure from one drug; adding a diuretic often adds more than raising the dose

Bottom line: Valsartan lowers blood pressure modestly, about as much as other ARBs and ACE inhibitors.

hospital stays for heart failure

Disease adjunct
Good Evidence

Val-HeFT randomized 5,010 people with heart failure (NYHA class II to IV, ejection fraction below 40 percent) already on standard treatment to valsartan (target 160 mg twice daily) or placebo for about 2 years. The combined endpoint of death, cardiac arrest with resuscitation, heart failure hospital stay or need for intravenous heart drugs was 13.2 percent lower on valsartan (relative risk 0.87), mainly from fewer heart failure hospital stays (13.8 versus 18.2 percent). The label says this benefit was driven largely by the 7 percent of patients not taking an ACE inhibitor, with little evidence of added benefit on top of an adequate ACE inhibitor dose. In a post hoc analysis, people taking valsartan with both an ACE inhibitor and a beta-blocker did worse, which raised a safety concern about that triple combination.

Effect size
About 13 percent lower combined morbidity and mortality; heart failure hospital stays 13.8 versus 18.2 percent
Time to effect
Assessed over about 2 years
Best fit
Adults with heart failure with reduced ejection fraction who cannot take an ACE inhibitor
Less likely
People already on an adequate dose of an ACE inhibitor, and especially those on both an ACE inhibitor and a beta-blocker

Bottom line: In one large trial, valsartan reduced heart failure hospital stays, mostly in people not on an ACE inhibitor.

Evidence is mixed

The overall combined endpoint favored valsartan, but a post hoc subgroup analysis suggested harm in people also taking both an ACE inhibitor and a beta-blocker, and the label attributes most of the benefit to the minority not taking an ACE inhibitor.

survival in chronic heart failure

No benefit found
Good Evidence

In the same Val-HeFT trial of 5,010 people with heart failure, deaths from any cause, one of the two primary endpoints, were similar on valsartan and placebo over about 2 years. The label reports 495 deaths (19.7 percent) on valsartan versus 484 (19.4 percent) on placebo (hazard ratio 1.02, 95 percent confidence interval 0.90 to 1.15). Valsartan is approved in heart failure to reduce hospital stays, not to prolong survival.

Effect size
No difference in deaths
Time to effect
Assessed over about 2 years
Best fit
Not applicable
Less likely
People with heart failure expecting valsartan alone to extend survival

Bottom line: Valsartan did not lower deaths in chronic heart failure.

survival after a heart attack with heart failure or a weakened heart

Disease adjunct
Good Evidence

VALIANT randomized 14,703 people 0.5 to 10 days after a heart attack complicated by heart failure, a weakened left ventricle, or both, to valsartan, captopril (an ACE inhibitor proven in this setting), or both. Over a median of 24.7 months, deaths were 979 on valsartan, 958 on captopril and 941 on the combination (hazard ratio 1.00 for valsartan versus captopril), meeting the trial's test for being no worse than captopril. Combining the two gave more drug-related side effects without better survival. Low blood pressure and kidney problems were more common with valsartan alone; cough, rash and taste changes with captopril.

Effect size
Same death rate as captopril (hazard ratio 1.00); no gain from combining them
Time to effect
Assessed over a median of about 2 years
Best fit
Adults after a heart attack with heart failure or a weakened heart, especially those who cannot take an ACE inhibitor
Less likely
People hoping to gain by taking valsartan together with an ACE inhibitor

Bottom line: After a heart attack with a weakened heart, valsartan was as effective as captopril; using both added side effects, not survival.

How it works

Angiotensin II is a hormone that tightens blood vessels and tells the adrenal glands to release aldosterone, which makes the kidneys keep salt and water and get rid of potassium. Valsartan blocks the AT1 receptor that angiotensin II acts on, so blood vessels relax and blood pressure falls, and it blocks angiotensin II's signal to release aldosterone. In people with high blood pressure the label reports only minimal falls in aldosterone and very little effect on potassium, but blood potassium can rise in some people, especially those with kidney disease or heart failure or who use other potassium-raising drugs and products. Unlike ACE inhibitors such as lisinopril, it blocks the receptor rather than the enzyme that makes angiotensin II, and in the label's comparisons dry cough was less common (2.6 percent versus 7.9 percent with an ACE inhibitor). About 25 percent of a tablet dose reaches the bloodstream, levels peak in 2 to 4 hours, and the half-life is about 6 hours, though the blood pressure effect lasts 24 hours at usual doses. Food lowers absorption by about 40 percent, but the label says it can be taken with or without food. Only about 20 percent is broken down (a small part by CYP2C9), and most leaves unchanged in the stool, so liver-enzyme drug interactions are unlikely. The label says the blood pressure effect is largely present within 2 weeks and reaches its maximum in about 4 weeks.

How to take it

1. Typical dose
Your prescriber sets the dose. The Diovan label gives: for adult high blood pressure, 80 or 160 mg once daily to start in people who are not volume-depleted, with a range of 80 to 320 mg once daily; adding a diuretic lowers blood pressure more than raising the dose above 80 mg. For children 1 to 16 years, 1 mg/kg once daily (up to 40 mg) to start, adjusted up to 4 mg/kg once daily (no more than 160 mg). For heart failure, 40 mg twice daily, raised to 80 and 160 mg twice daily or the highest dose tolerated. After a heart attack, starting as early as 12 hours afterwards, 20 mg twice daily, raised within 7 days to 40 mg twice daily and then toward a target of 160 mg twice daily. Diovan tablets and the oral suspension made from them are not interchangeable milligram for milligram, because the suspension gives about 60 percent more exposure. Prexxartan oral solution has its own label dosing, given twice daily: for adult high blood pressure, 40 or 80 mg twice daily to start (total 80 to 320 mg a day), and for children 6 to 16 years, 0.65 mg/kg twice daily to start (up to 40 mg a day), adjusted up to 1.35 mg/kg twice daily (no more than 160 mg a day). Its label says it is not therapeutically equivalent to Diovan tablets and is not recommended under 6 years of age, so the Diovan doses above do not apply to it.
2. Higher studied dose
320 mg a day, once daily for blood pressure or in divided doses in heart failure trials.
3. Timing
Once daily for blood pressure; twice daily for heart failure and after a heart attack. If you miss a dose, the label says to take it as soon as possible unless it is almost time for the next one, and not to double up.
4. With food
The label says valsartan can be taken with or without food; food lowers absorption of the tablet by about 40 percent, so taking it the same way each day keeps levels consistent.
5. Split dosing
Once daily for blood pressure; twice daily for heart failure and after a heart attack, as prescribed
6. How long to try
Usually long term. The label notes that stopping it has not been linked to a rapid rebound rise in blood pressure, but any change should be planned with your prescriber

What to track

Blood potassium and kidney function (creatinine), as your prescriber orders, especially after starting, a dose change or a new potassium product
Home blood pressure and dizziness or lightheadedness, especially when standing
Muscle weakness, an irregular heartbeat or unusual tiredness, which can be signs of high potassium (report promptly)
Any swelling of the face, lips, tongue or throat (seek care at once)
Pregnancy: tell your prescriber right away if you become pregnant
Any new pain reliever, since NSAIDs can strain the kidneys with valsartan

Bottom line: A prescriber sets the dose. Keep up with potassium and kidney blood tests, avoid potassium supplements and salt substitutes unless your prescriber approves them, and tell your doctor at once about a pregnancy.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Viral infections (3 versus 2 percent), tiredness (2 versus 1 percent) and abdominal pain (2 versus 1 percent) in high blood pressure trials; dizziness was more common at 320 mg (8 percent) than at 10 to 160 mg (2 to 4 percent)Dizziness (17 versus 9 percent on placebo) and low blood pressure (7 versus 2 percent) in heart failure trialsDiarrhea, joint pain and back pain in heart failure trialsHigher blood potassium (2 versus 1 percent in heart failure trials)Dry cough is less common than with ACE inhibitors (2.6 versus 7.9 percent)

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy (boxed warning): drugs that act on the renin-angiotensin system, used in the second and third trimesters, reduce the baby's kidney function and raise the risk of injury and death in the baby before and after birth, including low amniotic fluid, underdeveloped lungs, skull and bone defects, kidney failure and low blood pressure. The label says to consider another treatment and stop valsartan as soon as pregnancy is detected. If you could become pregnant, discuss contraception and alternatives with your doctor, and tell your prescriber right away if you think you are pregnant. Breastfeeding: it is not known whether valsartan passes into human milk; it does in rats, and because of the potential for serious harm to a breastfed infant, the label advises against breastfeeding during treatment.

Interactions

Aliskiren, ACE inhibitors (such as lisinopril) and other ARBsCritical

The label says dual blockade of the renin-angiotensin system raises the risk of low blood pressure, high potassium and kidney failure compared with one drug, and most people gain no extra benefit. Aliskiren with valsartan is contraindicated in diabetes and should be avoided with reduced kidney function; in the VALIANT trial, combining valsartan with captopril after a heart attack added side effects without better survival. Your prescriber decides whether any such combination is needed and how to monitor it.

Potassium supplements and potassium salt substitutesHigh

Blocking angiotensin II can make the kidneys hold on to potassium. The Diovan label says potassium supplements, salt substitutes containing potassium, potassium-sparing diuretics (such as spironolactone) and other drugs that raise potassium can increase blood potassium and, in heart failure, creatinine, and advises potassium monitoring if they are used together. Check labels for potassium chloride (common in "lite" or low-sodium salts) and use these products only if your prescriber has approved them and is checking your blood tests.

LithiumHigh

The label reports rises in lithium levels and lithium toxicity when lithium was taken with ARBs, and calls for monitoring lithium levels during combined use. Make sure the prescriber who manages your lithium knows you take valsartan.

Celery juice and celery seed extractModerate

In a 4-week randomized crossover trial in 52 people with high blood pressure, celery seed extract capsules (1.34 g a day) lowered 24-hour systolic pressure from 141.2 to 130.0 mmHg, with no change on placebo; celery juice itself has not been tested. Regular use could add to valsartan's effect and push readings lower than intended. Check your home blood pressure, watch for dizziness on standing, and review it with your doctor or pharmacist.

NSAID pain relievers (ibuprofen, naproxen, celecoxib)Moderate

In older adults, people who are dehydrated or on diuretics, and people with reduced kidney function, NSAIDs plus valsartan can worsen kidney function, sometimes to acute kidney failure, usually reversibly; NSAIDs can also blunt valsartan's blood pressure effect. The label advises periodic kidney checks, so ask your doctor or pharmacist before using NSAIDs regularly.

SpirulinaLow

A 2025 meta-analysis of randomized trials, rated moderate certainty by its authors, found spirulina lowered systolic blood pressure by about 4.4 mmHg and diastolic by about 2.8 mmHg, more clearly in people with high blood pressure. Combined with valsartan the effects may add a little; no study has tested the pair. Watch your home readings when you start it, and if you have kidney disease or take other potassium-raising medicines, ask your doctor or pharmacist before using it.

Documented interactions

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

An FDA-approved valsartan product dispensed on your own prescription: Diovan or generic valsartan tablets, or Prexxartan oral solution
The strength printed clearly (40, 80, 160 or 320 mg tablets), and for combination pills every active ingredient listed, so your pharmacist can make sure the same ingredient is not prescribed twice
A pharmacy leaflet with the boxed pregnancy warning and advice about potassium supplements and salt substitutes

Be skeptical of…

"Lite" or low-sodium salts and potassium supplements with no warning for people on blood pressure medicines: most contain potassium chloride
"Natural blood pressure" blends (celery, spirulina and similar) presented as replacements for valsartan or as harmless add-ons
"Heart health" or electrolyte drinks and powders high in potassium marketed without a kidney or medication caution
Any product or advice suggesting valsartan is safe to continue during pregnancy

Frequently asked questions

Can I take potassium supplements or use salt substitutes with valsartan?⌄

Only if your prescriber has approved it and is checking your blood potassium. The label says potassium supplements and salt substitutes containing potassium can raise blood potassium with valsartan, and rises are more likely with kidney problems or heart failure. Many "lite" and low-sodium salts are potassium chloride, so read the ingredient list and ask your pharmacist.

Do I need to avoid bananas and other high-potassium foods on valsartan?⌄

The Diovan label does not restrict foods; its potassium warnings are about supplements, potassium salt substitutes and potassium-raising drugs. The risk of high potassium rises with kidney disease and heart failure, so some people are given a diet plan. Follow the diet and blood-test plan your prescriber gives you, and ask before making a big change in your diet.

Can I take spirulina or celery seed with valsartan?⌄

Both may lower blood pressure a little on their own: spirulina by about 4/3 mmHg in a meta-analysis of trials, and celery seed extract in one small trial. Neither has been tested with valsartan. Watch your home readings for lows or dizziness on standing, and check with your doctor or pharmacist first if you have kidney disease.

Is it safe to take ibuprofen or naproxen with valsartan?⌄

Occasional use may be fine for many people, but the label warns that NSAIDs with valsartan can worsen kidney function, especially in older adults, people who are dehydrated or on diuretics, and people with kidney problems, and can blunt the blood pressure effect. Ask your doctor or pharmacist before using them regularly.

What if I become pregnant while taking valsartan?⌄

Tell your prescriber right away. Valsartan carries a boxed warning because drugs of this type can injure and kill a developing baby, mainly in the second and third trimesters, and the label says to stop it as soon as pregnancy is detected and consider another treatment. If you could become pregnant, talk with your doctor about contraception and alternatives ahead of time.

Will valsartan give me a cough like lisinopril did?⌄

It is much less likely. In the label's comparisons, dry cough occurred in 2.6 percent of people on valsartan versus 7.9 percent on an ACE inhibitor, and in people who had coughed on an ACE inhibitor before, cough recurred in 20 percent on valsartan versus 69 percent on lisinopril. Tell your prescriber if a cough develops.

References by claim

blood pressure

Heran et al., 2008 · PMC (2008) link

hospital stays for heart failure

Cohn et al., 2001 · PubMed (2001) link

survival after a heart attack with heart failure or a weakened heart

Pfeffer et al., 2003 · PubMed (2003) link

Safety

Diovan (valsartan) tablets prescribing information · DailyMed (FDA label) link

Prexxartan (valsartan) oral solution prescribing information · DailyMed (FDA label) link

Interaction: Celery juice and celery seed extract

Shayani Rad et al., 2022 · PubMed (2022) link

Interaction: Spirulina

Shiri et al., 2025 · PubMed (2025) link

Track Valsartan with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.